+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

First-line therapy for "high-risk prostate cancer". HELP - high intensity focused ultrasound (HIFU) and Eilgard in patients with high-risk prostate cancer - a prospective, randomized study (AP 62/10 of the AUO)



First-line therapy for "high-risk prostate cancer". HELP - high intensity focused ultrasound (HIFU) and Eilgard in patients with high-risk prostate cancer - a prospective, randomized study (AP 62/10 of the AUO)



Der Urologe. Ausg. a 53(7): 1063-1064




(PDF emailed within 0-6 h: $19.90)

Accession: 053252743

Download citation: RISBibTeXText

PMID: 24939285

DOI: 10.1007/s00120-014-3515-3


Related references

First-line therapy for low-risk prostate cancer: prospective phase II study of focal therapy (hemiablation) of the prostate with high intensity focused ultrasound (HIFU) in patients suitable for "Active Surveillance" (AP 68/11 of the AUO). Der Urologe. Ausg. a 53(3): 382-383, 2014

High-intensity focused ultrasound (HIFU) in prostate cancer: a single centre experience in patients with low, intermediate or high-risk of progression. Archivio Italiano di Urologia, Andrologia 82(4): 253-255, 2011

Anesthetic management for high-intensity focused ultrasound (HIFU) therapy in prostate cancer patients. Masui. Japanese Journal of Anesthesiology 56(4): 446-449, 2007

Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study. Bju International 114(4): 532-540, 2014

Treatment of localised prostate cancer by high intensity focused ultrasound (HIFU); Results of the first french prospective study on patients not previously treated: Minimum of five years follow-up. 2008

Treatment of localized prostate cancer by high intensity focused ultrasound (HIFU); Results of the first french prospective study on patients not previously treated: Minimum of five years of followup. 2008

Salvage high-intensity focused ultrasound (HIFU) therapy for locally recurrent prostate cancer after primary HIFU or external beam radiotherapy (EBRT). European Urology Supplements 7(3): 119, 2008

Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer. Bju International 98(6): 1193-1198, 2006

Acute Toxicity Rates in Patients Receiving Salvage Radical Prostate Irradiation Following Primary High Intensity Focused Ultrasound (HIFU) for Localised Prostate Cancer. Clinical Oncology 24(2): 155-0, 2012

Clinical predictor of high intensity focused ultrasound (HIFU) therapy failure for the localized prostate cancer. 2007

Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients. Bju International 119(6): 896-904, 2017

Anterior perirectal fat tissue diminishes the focusing energy by transrectal high-intensity focused ultrasound (HIFU) and strongly influences the outcome of prostate cancer patients after hifu treatment. Journal of Urology 179(4): 45-46, 2008

Extra-target low-risk prostate cancer: implications for focal high-intensity focused ultrasound of clinically significant prostate cancer. World Journal of Urology 2018, 2018

High-intensity focused ultrasound (HIFU) for prostate cancer. Cancer Control 14(3): 244-249, 2007

Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1. Clinical Hemorheology and Microcirculation 69(1-2): 93-100, 2018